These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8243830)

  • 21. Two sequences flanking the major autophosphorylation site of the insulin receptor are essential for tyrosine kinase activation.
    Leconte I; Clauser E
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):465-72. PubMed ID: 7887900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing.
    Roach P; Zick Y; Formisano P; Accili D; Taylor SI; Gorden P
    Diabetes; 1994 Sep; 43(9):1096-102. PubMed ID: 8070609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
    De Fea K; Roth RA
    Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postbinding characterization of five naturally occurring mutations in the human insulin receptor gene: impaired insulin-stimulated c-jun expression and thymidine incorporation despite normal receptor autophosphorylation.
    Quon MJ; Cama A; Taylor SI
    Biochemistry; 1992 Oct; 31(41):9947-54. PubMed ID: 1390778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of an insulin receptor mutant lacking the subunit processing site.
    Williams JF; McClain DA; Dull TJ; Ullrich A; Olefsky JM
    J Biol Chem; 1990 May; 265(15):8463-9. PubMed ID: 2187866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action.
    Cama A; Quon MJ; de la Luz Sierra M; Taylor SI
    J Biol Chem; 1992 Apr; 267(12):8383-9. PubMed ID: 1314826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of unprocessed insulin proreceptors in COS 7 cells transfected with cDNA with Arg735----Ser735 point mutation at the cleavage site.
    Sugibayashi M; Shigeta Y; Teraoka H; Kobayashi M
    Metabolism; 1992 Aug; 41(8):820-6. PubMed ID: 1640858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfection of cDNA with G----T point mutation at the cleavage site of insulin receptors to COS 7 cells.
    Kobayashi M; Sugibayashi M; Sasaoka T; Egawa K; Shigeta Y; Tamaki M; Nakamura E; Teraoka H
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1073-8. PubMed ID: 2322258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to the extracellular receptor domain restore the hormone-insensitive kinase and conformation of the mutant insulin receptor valine 382.
    Lebrun C; Baron V; Kaliman P; Gautier N; Dolais-Kitabgi J; Taylor S; Accili D; Van Obberghen E
    J Biol Chem; 1993 May; 268(15):11272-7. PubMed ID: 8388389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance.
    Carrera P; Cordera R; Ferrari M; Cremonesi L; Taramelli R; Andraghetti G; Carducci C; Dozio N; Pozza G; Taylor SI
    Hum Mol Genet; 1993 Sep; 2(9):1437-41. PubMed ID: 8242067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
    Grako KA; Olefsky JM; McClain DA
    Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action.
    Formisano P; Sohn KJ; Miele C; Di Finizio B; Petruzziello A; Riccardi G; Beguinot L; Beguinot F
    J Biol Chem; 1993 Mar; 268(7):5241-8. PubMed ID: 8383132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor alpha-subunit in a patient with leprechaunism: binding, phosphorylation, and biological activity.
    Jospe N; Zhu J; Liu R; Livingston JN; Furlanetto RW
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1294-302. PubMed ID: 7962321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance.
    Kadowaki T; Bevins CL; Cama A; Ojamaa K; Marcus-Samuels B; Kadowaki H; Beitz L; McKeon C; Taylor SI
    Science; 1988 May; 240(4853):787-90. PubMed ID: 2834824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor.
    Macaulay SL; Polites M; Frenkel MJ; Hewish DR; Ward CW
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):811-20. PubMed ID: 7702578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of the high cysteine region of the human insulin receptor alpha-subunit increases insulin receptor binding affinity and transmembrane signaling.
    Rafaeloff R; Patel R; Yip C; Goldfine ID; Hawley DM
    J Biol Chem; 1989 Sep; 264(27):15900-4. PubMed ID: 2550426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.
    Frankel M; Ablooglu AJ; Leone JW; Rusinova E; Ross JB; Heinrikson RL; Kohanski RA
    Mol Cell Biol; 2001 Jul; 21(13):4197-207. PubMed ID: 11390649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface.
    Maassen JA; Van der Vorm ER; Van der Zon GC; Klinkhamer MP; Krans HM; Möller W
    Biochemistry; 1991 Nov; 30(44):10778-83. PubMed ID: 1931997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional properties of a heterozygous mutation (Arg1174-->Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient.
    Moritz W; Froesch ER; Böni-Schnetzler M
    FEBS Lett; 1994 Sep; 351(2):276-80. PubMed ID: 8082780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.